AbbVie
ABBV
$227.00
Share price
0.76%
Change (1 day)
1.60%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
EPS for AbbVie (ABBV)
EPS in 2023 (TTM): $4.98
According to AbbVie's latest financial reports the company's current EPS (TTM) is $4.83. In 2022 the company made an earnings per share (EPS) of $8.74 an increase over its 2021 EPS that were of $8.51.
EPS history for AbbVie from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $4.98 | -43.04% |
| 2022 | $8.74 | 2.63% |
| 2021 | $8.51 | 125.21% |
| 2020 | $3.78 | -45.69% |
| 2019 | $6.96 | 48.35% |
| 2018 | $4.69 | 7.6% |
| 2017 | $4.36 | -9.3% |
| 2016 | $4.81 | 15.48% |
| 2015 | $4.16 | 185.53% |
| 2014 | $1.46 | -57.11% |
| 2013 | $3.40 | -21.69% |
| 2012 | $4.34 | 55.73% |
| 2011 | $2.79 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $2.44 | -49.47% | 🇺🇸 USA |
 | $5.21 | 7.86% | 🇺🇸 USA |
 | $7.12 | 47.51% | 🇺🇸 USA |
 | $18.57 | 284.44% | 🇺🇸 USA |
 | $5.76 | 19.27% | 🇺🇸 USA |
 | $24.22 | 401.54% | 🇺🇸 USA |
 | $4.59 | -4.89% | 🇬🇧 UK |
 | $2.60 | -46.07% | 🇬🇧 UK |
 | $2.57 | -46.75% | 🇺🇸 USA |